Response of gastric inhibitory polypeptide (GIP) to test meal in chronic pancreatitis--relationship to endocrine and exocrine insufficiency
- PMID: 1001849
- DOI: 10.1007/BF01220638
Response of gastric inhibitory polypeptide (GIP) to test meal in chronic pancreatitis--relationship to endocrine and exocrine insufficiency
Abstract
Twenty-nine patients with chronic pancreatitis had a significantly greater IR-GIP response to a test meal than 15 controls. This increased response was not related to the degree of steatorrhoea or glucose intolerance. It was most marked in a group of patients with moderately impaired IRI release and medium steatorrhoea. From this is concluded that the IR-GIP response to a test meal is determined by at least two factors: 1. feedback control via insulin secretion, 2. assimilation of fat. In chronic pancreatitis endocrine insufficiency may induce an exaggerated GIP response and severe exocrine insufficiency may prevent fat induced GIP release. Gastrin is not involved in the different GIP response in patients with chronic pancreatitis.
Similar articles
-
Clinical aspects of GIP secretion.Acta Diabetol Lat. 1982 Jan-Mar;19(1):1-11. doi: 10.1007/BF02581180. Acta Diabetol Lat. 1982. PMID: 6280423 Review.
-
Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution.Diabetologia. 1980 Sep;19(3):198-204. doi: 10.1007/BF00275269. Diabetologia. 1980. PMID: 6997121
-
Gastric inhibitory polypeptide (GIP), gastrin and insulin: response to test meal in coeliac disease and after duodeno-pancreatectomy.Diabetologia. 1976 Jul;12(3):279-86. doi: 10.1007/BF00422096. Diabetologia. 1976. PMID: 955338
-
Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.Scand J Gastroenterol. 1978;13(1):41-7. doi: 10.3109/00365527809179804. Scand J Gastroenterol. 1978. PMID: 635445
-
Conflicting gastric inhibitory polypeptide data: possible causes.Diabetes Res Clin Pract. 1993 Feb;19(2):93-101. doi: 10.1016/0168-8227(93)90102-b. Diabetes Res Clin Pract. 1993. PMID: 8472632 Review.
Cited by
-
Glucose-dependent insulinotropic polypeptide (GIP).Mol Metab. 2025 May;95:102118. doi: 10.1016/j.molmet.2025.102118. Epub 2025 Feb 28. Mol Metab. 2025. PMID: 40024571 Free PMC article. Review.
-
Glucose-dependent insulinotropic peptide: structure of the precursor and tissue-specific expression in rat.Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1992-6. doi: 10.1073/pnas.90.5.1992. Proc Natl Acad Sci U S A. 1993. PMID: 8446620 Free PMC article.
-
Pharmacokinetic-pharmacodynamic relationships of Acarbose.Clin Pharmacokinet. 1996 Feb;30(2):94-106. doi: 10.2165/00003088-199630020-00002. Clin Pharmacokinet. 1996. PMID: 8906894 Review.
-
Clinical aspects of GIP secretion.Acta Diabetol Lat. 1982 Jan-Mar;19(1):1-11. doi: 10.1007/BF02581180. Acta Diabetol Lat. 1982. PMID: 6280423 Review.
-
The role of incretins in glucose homeostasis and diabetes treatment.Pharmacol Rev. 2008 Dec;60(4):470-512. doi: 10.1124/pr.108.000604. Epub 2008 Dec 12. Pharmacol Rev. 2008. PMID: 19074620 Free PMC article. Review.